89. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Freitag, 14. April 2023 (Posterbereich 15) 10:00-11:30

Postervorträge

Hypertrophie bei TAVI / PFO

Diskussionsleitung: S. Jung (Erlangen), F. X. Kleber (Lutherstadt - Wittenberg)

(P1325) Relation between hypertrophy pattern and clinical outcome after TAVR
    V. Obermeier, G. Buglio, R. Thalmann, H. Seoudy, C. Neururer, L. Preuss, A. Stundl, P. Hoppmann, K.-L. Laugwitz, D. Frank, C. Kupatt (München, Kiel)
(P1326) Improved diastolic function correlates with better functional capacity after native valve-preserving aortic valve surgery compared to conventional prosthetic valve replacement in non-elderly adults
    T. Holst, X. Hua, J. Petersen, B. Waschki, C. Sinning, M. Rybczynski, H. Reichenspurner, E. Girdauskas (Augsburg, Hamburg, Itzehoe)
(P1327) Histological Patterns of Cardiac Fibrosis as Predictors for Sudden Cardiac Death and Heart Failure Death after Transcatheter Aortic Valve Implantation
    F. Alnour, B. E. Beuthner, G. Hasenfuß, M. Puls, E. Zeisberg, für die Studiengruppe: CRC1002 (Göttingen)
(P1328) Mortality rate in patients with severe symptomatic aortic valve stenosis waiting for TAVR - a retrospective analysis
    I. Eckardt, J. Shamekhi, S. Zimmer, G. Nickenig, B. Al-Kassou, A. Sugiura (Bonn)
(P1329) Mosaic loss of Y chromosome in peripheral blood cells impairs survival in patients with severe aortic stenosis after successful TAVR
    S. Mas-Peiro, W. Abplanalp, T. Rasper, G. Pergola, A. Berkowitsch, D. Leistner, S. Dimmeler, A. M. Zeiher (Frankfurt am Main)
(P1330) A systematic review and meta-analysis of new-onset atrial fibrillation after percutaneous patent foramen ovale closure
    D. Jurczyk, S. Macherey-Meyer, E. Rawish, T. Stiermaier, I. Eitel, C. Frerker, T. Schmidt (Lübeck, Köln)
(P1331) Interventional PFO closure- long term results of a large PFO single center registry
    S. Möbius-Winkler, B. Schulte-Huermann, A. Hamadanchi, G. Dannberg, I. Dähnert, H.-R. Figulla, C. Schulze, M. Franz (Jena, Leipzig)
(P1332) Histological Assessment of Cardiac Amyloidosis in Patients Undergoing TAVR
    B. E. Beuthner, M. Elkenani, K. Evert, J. Mustroph, T. Seidler, E. M. Zeisberg, G. Hasenfuß, M. Puls, K. Toischer (Göttingen, Regensburg)